NC-P7

N/A

Report date: 2024/11/14 15:48:40
NME

Base Information

Drug NameNC-P7
Drug Alias NameNC-P7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLymphocyte differentiation antigen CD38 modulators
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsHeart DiseasesKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEncefa
China Registration ClassN/A

Develop Information

Active CompaniesEncefa
Inactive CompaniesN/A
Active IndicationsHeart DiseasesKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A